Biopharmaceutical in vitro characterization of CPZEN-45, a drug candidate for inhalation therapy of tuberculosis.
暂无分享,去创建一个
C. Ehrhardt | C. Lehr | A. Hickey | H. Huwer | N. Daum | J. Salomon | Diana Severynse-Stevens | Pauline Galeron | Nanette E Schulte | Paul R Morow
[1] R. Mehta,et al. Effect of verapamil on systemic exposure and safety of umeclidinium and vilanterol: a randomized and open-label study , 2013, International journal of chronic obstructive pulmonary disease.
[2] Dae-Duk Kim,et al. Chitosan microspheres as an alveolar macrophage delivery system of ofloxacin via pulmonary inhalation. , 2013, International journal of pharmaceutics.
[3] J. Engohang-Ndong,et al. Antimycobacterial drugs currently in Phase II clinical trials and preclinical phase for tuberculosis treatment , 2012, Expert opinion on investigational drugs.
[4] C. Ehrhardt,et al. Transport of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (ASP+) in human respiratory epithelial cells. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[5] C. Ehrhardt,et al. Organic cation transporters in the blood-air barrier: expression and implications for pulmonary drug delivery. , 2012, Therapeutic delivery.
[6] J. O’Grady,et al. Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. , 2012, The Journal of infectious diseases.
[7] M. Gonzalez-Juarrero,et al. Mouse Model for Efficacy Testing of Antituberculosis Agents via Intrapulmonary Delivery , 2012, Antimicrobial Agents and Chemotherapy.
[8] A. Healy,et al. In Vitro and In Vivo Characterisation of PEG-Lipid-Based Micellar Complexes of Salmon Calcitonin for Pulmonary Delivery , 2012, Pharmaceutical Research.
[9] L. Zakharova,et al. Self-assembling systems based on amphiphilic alkyltriphenylphosphonium bromides: elucidation of the role of head group. , 2012, Journal of colloid and interface science.
[10] C. Ehrhardt,et al. Nanoparticles attenuate P-glycoprotein/MDR1 function in A549 human alveolar epithelial cells. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[11] G. Cavallaro,et al. Phospholipid-polyaspartamide micelles for pulmonary delivery of corticosteroids. , 2011, International journal of pharmaceutics.
[12] Eric Arnoult,et al. The challenge of new drug discovery for tuberculosis , 2011, Nature.
[13] J. Sadoff,et al. Update on research and development pipeline: tuberculosis vaccines. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] C. Bosquillon,et al. Drug transporters in the lung--do they play a role in the biopharmaceutics of inhaled drugs? , 2010, Journal of pharmaceutical sciences.
[15] A. Hickey,et al. Inhaled Drug Delivery for Tuberculosis Therapy , 2009, Pharmaceutical Research.
[16] C. Ehrhardt,et al. In vitro cell culture models for the assessment of pulmonary drug disposition , 2008 .
[17] Malgorzata Smola,et al. Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases , 2008, International journal of nanomedicine.
[18] R. Peters,et al. From fluorescence nanoscopy to nanoscopic medicine. , 2008, Nanomedicine.
[19] M. Gumbleton,et al. P-glycoprotein (MDR1) functional activity in human alveolar epithelial cell monolayers , 2007, Cell and Tissue Research.
[20] A. Wanner,et al. Epithelial organic cation transporters ensure pH-dependent drug absorption in the airway. , 2007, American journal of respiratory cell and molecular biology.
[21] V. Torchilin,et al. Micellar Nanocarriers: Pharmaceutical Perspectives , 2006, Pharmaceutical Research.
[22] E. Rieber,et al. Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells , 2006, Cell and Tissue Research.
[23] Ben Forbes,et al. Human respiratory epithelial cell culture for drug delivery applications. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[24] H. Naganawa,et al. Caprazamycins, Novel Lipo-nucleoside Antibiotics, from Streptomyces sp. , 2005, The Journal of Antibiotics.
[25] R. Pandey,et al. Antitubercular inhaled therapy: opportunities, progress and challenges. , 2005, The Journal of antimicrobial chemotherapy.
[26] H. Naganawa,et al. Caprazamycin B, a novel anti-tuberculosis antibiotic, from Streptomyces sp. , 2003, The Journal of antibiotics.
[27] K. Audus,et al. P-glycoprotein efflux pump expression and activity in Calu-3 cells. , 2001, Journal of pharmaceutical sciences.
[28] D. Hokey,et al. Aerosol vaccines for tuberculosis: a fine line between protection and pathology. , 2011, Tuberculosis.
[29] M. Gumbleton,et al. Spatial expression and functionality of drug transporters in the intact lung: objectives for further research. , 2011, Advanced drug delivery reviews.
[30] P. Colombo,et al. Inhaled drug therapy for treatment of tuberculosis. , 2011, Tuberculosis.